tratamiento tirzepatide Estados Unidos aprueba tirzepatida para el manejo de la obesidad medicamento tirzepatide 💉¿Dudas sobre tirzepatida?

Compared to other GLP-1 agonists, tirzepatide offers enhanced efficacy in both blood sugar control and weight loss

Common gastrointestinal side effects (nausea, bloating) may make rich or sweet foods less appealing during treatment

Nature 544, 250254

Adipocyte hypertrophy, fatty liver and metabolic risk factors in south asians: The molecular study of health and risk in ethnic groups (mol-SHARE)

Injectable GLP-1s bypass the digestive system entirely, delivering the medication into the subcutaneous fat layer where its slowly absorbed into the bloodstream over the course of a week

Some patients in the trials reported gastrointestinal issues, such as nausea and vomiting, which are known side effects of semaglutide